国药控股(01099)公布前三季度业绩 归母净利约60.96亿元 同比增长4.09%

Sinopharm Holdings (01099) announced the first three quarter results, net profit of about 6.096 billion yuan, up 4.09% year-on-year

Zhitong Finance ·  10/30/2023 07:49

According to the Zhitong Finance App, Sinopharm Holdings (01099) announced that in the first three quarters of 2023, total operating income was about 445.92 billion yuan, up 9.73% year on year; net profit attributable to owners of the parent company was about 6.096 billion yuan, up 4.09% year on year; basic earnings per share of 1.96 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment